Literature DB >> 2759756

Prognostic index in prediction of mortality from infective endocarditis.

K S Woo1, Y M Lam, H T Kwok, L K Tse, J Vallance-Owen.   

Abstract

Out of 176 patients with infective endocarditis complicating rheumatic (120) and congenital heart disease (38), mortality occurred in 35 patients (19.9%). Presence of leukocytosis, heart failure, major embolisation and isolation of certain organisms including Staphylococci, beta-haemolytic Streptococci, Pseudomonas and Klebsiella were ominous with higher mortality rates compared with those when they were absent (P less than 0.02). Stepwise logistic multiple regression was then applied and the four most important independent variables were identified. A prognostic index for the prediction of mortality for infective endocarditis was then constructed by the summation of the regression coefficients. By applying this index, patients with infective endocarditis could be divided into subgroups with increasing proportional mortality from 5.8 to 83.3%. It provides an objective assessment of the risk patients with infective endocarditis, and a more reliable evaluation of benefit of any new treatment regimen, including cardiac surgery, during the acute stage.

Entities:  

Mesh:

Year:  1989        PMID: 2759756     DOI: 10.1016/0167-5273(89)90040-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995.

Authors:  R O Netzer; E Zollinger; C Seiler; A Cerny
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

2.  Clinical features and predictors for mortality in patients with infective endocarditis at a university hospital in Taiwan from 1995 to 2003.

Authors:  C-N Hsu; J-Y Wang; C-D Tseng; J-J Hwang; P-R Hsueh; C-S Liau
Journal:  Epidemiol Infect       Date:  2005-10-20       Impact factor: 2.451

3.  Infective endocarditis in a district general hospital.

Authors:  M Manford; J Matharu; K Farrington
Journal:  J R Soc Med       Date:  1992-05       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.